Curcumin C3 Complex

Curcumin C3 Complex

Jigsaw Health4.7 (27 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$34.97 $0.58 per serving

Product analysis

56 out of 100

Curcumin C3 Complex offers a simple curcumin supplement with a possible role in joint comfort. Benefits depend on the preparation, and the details do not establish a match to the forms behind the relevant findings.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Turmeric and total curcuminoids are identified, but their quality cannot be established confidently. Missing mixture details limit how closely the preparation can be compared with other forms.

Ingredient Transparency80

The curcumin amount and source are disclosed, making the main ingredient easier to identify. The makeup of the mixture is not fully explained, limiting a closer comparison.

Value For Money40

The labeled serving offers limited price value. The uncertain match to preparations associated with benefits makes a premium harder to justify.

Customer Satisfaction70

Customer ratings are favorable. The very small review base makes that pattern less reliable than broader feedback would be.

Product Focus63

The single-ingredient formula keeps curcumin central across its proposed uses. Benefits for joints, liver markers or memory depend on specific preparations and cannot be assumed here.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.58
Customer rating
4.7 · 27 ratings
Report analysis

Goals

Joint Health
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Curcumin · 500 mg

Curcumin at 500 mg relates to joint comfort through inflammation-related processes. The supplied assessment does not match C3 Complex to the specific BCM-95/Curcugreen preparation behind the relevant evidence, so symptom findings transfer only partly and do not demonstrate structural joint repair.

How this product is rated for Joint Health

Ingredient fit75

The relevant ingredients are a clear focus of the formula. The assessed amounts partly meet the saved comparison benchmarks.
Goal fit
The relevant ingredients are a clear focus of the formula.
Dose adequacy
The assessed amounts partly meet the saved comparison benchmarks.

Pathways9

The strongest assessed area is inflammation control, with limited coverage. No assessed area reaches the threshold for substantial coverage.
Depth
The strongest assessed area is inflammation control, with limited coverage.
Breadth
No assessed area reaches the threshold for substantial coverage.

Evidence27

Curcumin provides the strongest evidence contribution among the assessed ingredients, with important limits on specific joint-comfort benefits. The assessed ingredients do not match the recognized trial preparations.
Evidence strength
Curcumin provides the strongest evidence contribution among the assessed ingredients, with important limits on specific joint-comfort benefits.
Studied preparation
The assessed ingredients do not match the recognized trial preparations.

Formulation logic100

The assessed ingredients can contribute independently or have their required partner. No configured ingredient conflict was matched in the supplied assessment. All ingredients included in this check reach its minimum amount threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold.
Study evidence
Curcumin Supportive 62 studies
Inflammation
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceB Formulation Logic
Curcumin · 500 mg

Curcumin may help with knee osteoarthritis pain and function, but that is different from reducing inflammation throughout the body. The useful symptom connection depends on the particular preparation. Here the 500 mg declaration does not identify the matching curcumin preparation, so its amount alone cannot tell you whether to expect the same relief.

How this product is rated for Inflammation

Ingredient fit75

Curcumin provide the relevant ingredient connection. Their usefulness depends on the benefit, amount and preparation, rather than the number of ingredients.
Goal fit
Curcumin provides the ingredient connection to inflammation; other actives need not add a distinct benefit.
Dose adequacy
Curcumin 500 mg. These are amounts per selected serving, not a daily regimen or proof of effectiveness.

Pathways9

The main ingredient connection concerns inflammatory gene signalling. This biological route does not predict the extent of everyday relief.
Depth
The strongest ingredient connection concerns inflammatory gene signalling, which describes a biological route rather than predictable symptom relief.
Breadth
The relevant connections are limited to inflammatory gene signalling; this does not imply comprehensive inflammation relief.

Evidence32

Curcumin has preparation-specific relevance to knee osteoarthritis symptoms, with uncertainty when the material is unidentified.
Evidence strength
Curcumin has relevant but qualified inflammation context; a marker or symptom finding does not guarantee broad benefit.
Studied preparation
A relevant preparation is unidentified, so its effects cannot be assumed to match those of a specific preparation.

Formulation logic76

Curcumin has an unidentified preparation and lacks the associated partner. No particular ingredient conflict is identified.
Partner coverage
Curcumin lacks the partner associated with its preparation-specific context; no added combination benefit can be assumed.
Conflicts
No particular ingredient conflict is identified for this goal.
Effective doses
Curcumin has a declared amount relevant to its ingredient comparison; this alone does not prove symptom relief.
Study evidence
Curcumin Supportive 68 studies
Longevity
Impact
High effect
B- Ingredient FitD- PathwaysA EvidenceA+ Formulation Logic
Curcumin · 500 mg

Curcumin is connected to inflammation-related processes, but the supplied human memory findings are uncertain and specific to Theracurmin. The pilot included people with mild cognitive impairment, and benefit in the healthy subgroup was not established. The saved result recognizes the 500 mg serving, but C3 Complex cannot be assumed equivalent to that preparation or to prevent dementia or extend life.

How this product is rated for Longevity

Ingredient fit75

The formula's focus and amounts produce a partial fit with the saved ingredient references. The overall roles remain bounded by the specific evidence for this product.
Goal fit
The relevant ingredients are concentrated on this goal, although links to other uses affect its focus.
Dose adequacy
The recognized amounts only partly match the saved references; this does not define a proven effective anti-aging dose.

Pathways40

The saved findings are strongest for chronic inflammation control, with limited breadth across the other aging-related processes.
Depth
The strongest saved finding concerns chronic inflammation control; this describes ingredient roles rather than a demonstrated slowing of aging.
Breadth
Only one pathway reaches the saved coverage threshold, leaving the formula's recognized reach narrow.

Evidence95

Curcumin drives the leading saved evidence finding. The ingredient-specific limitations above still restrict which practical benefits can be expected.
Evidence strength
Curcumin supplies the leading saved evidence finding, but its specific population and outcome limitations still apply.
Studied preparation
The saved findings recognize preparation matches for the qualifying ingredients; this does not extend their evidence to broader aging outcomes.

Formulation logic100

The saved formulation findings identify no matched conflicts and no missing required partners. Amount limitations are retained in the individual findings.
Partner coverage
The recognized ingredients either work independently or have their required partner; no extra combination benefit is established.
Conflicts
No matched ingredient conflict was recorded in the supplied calculation.
Effective doses
All recognized ingredients meet the saved amount threshold, which is a calculation reference rather than proof of anti-aging efficacy.
Study evidence
Curcumin Supportive 6 studies
Liver & Detox
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Curcumin · 500 mg

Curcumin has a preparation-specific connection to liver markers in adults with fatty liver disease. The reviewed study used a phytosomal preparation, which cannot be assumed equivalent to the unidentified curcumin form here. The 500 mg per serving does not establish active content equivalent to a phospholipid complex or demonstrate generalized toxin clearance.

How this product is rated for Liver & Detox

Ingredient fit75

Curcumin provides the main connection. The amounts provide only a partial match to the reference comparisons.
Goal fit
Curcumin supplies a goal-related connection within a formula also associated with other health goals.
Dose adequacy
The included amounts provide a partial match to reference comparisons, rather than established doses for toxin removal.

Pathways19

The main mapped connection concerns detoxification-enzyme activity, without demonstrating improved human toxin clearance. No pathway reached the comparison threshold; the mechanistic connection remains limited.
Depth
The main mapped connection concerns detoxification-enzyme activity, without demonstrating improved human toxin clearance.
Breadth
No pathway reached the comparison threshold; the mechanistic connection remains limited.

Evidence81

Curcumin evidence concerns a phytosomal preparation and fatty-liver endpoints, rather than generalized toxin removal.
Evidence strength
Curcumin evidence concerns a phytosomal preparation and fatty-liver endpoints, rather than generalized toxin removal.
Studied preparation
The included ingredient has a preparation match in the saved comparison, which does not establish equivalent clinical toxin-clearance outcomes.

Formulation logic100

No missing required partner or configured conflict was identified. The included ingredients meet the minimum exposure comparison.
Partner coverage
No missing required partner was identified; combining these ingredients does not establish an extra detoxification benefit.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
The included ingredients meet the minimum exposure comparison, which does not establish a clinically effective detoxification dose.
Study evidence
Curcumin Supportive 30 studies

Ingredients

IngredientAmount per servingScore
Curcumin C3 Complex (Curcuma longa, Total Curcuminoids)
500 mg 64
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
A+ Composition And Label DisclosureD- Composition And Label DisclosureD- Commercial Price And Usability
Each serving contains 500 mg of a curcumin preparation with a 95% total-curcuminoid disclosure. The stated concentration helps distinguish the active constituents from the preparation's weight.
How this ingredient is rated

Composition and Label Disclosure100

The saved facts record a 95% total-curcuminoid disclosure for the 500 mg preparation.
Curcuminoid Amount Disclosure
The saved facts record a 95% total-curcuminoid disclosure for the 500 mg preparation.

Composition and Label Disclosure40

The saved facts record a 95% total-curcuminoid disclosure for the 500 mg preparation.
Preparation and Marker Disclosure
The saved facts record a 95% total-curcuminoid disclosure for the 500 mg preparation.

Commercial Price and Usability40

The whole-product price is about $0.58 per labeled serving.
Commercial Price per Labeled Serving
The whole-product price is about $0.58 per labeled serving.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
    Zhang F; Niu B · Medicine · 2025
    Meta-analysis7 studies pooledInflammation forCurcumin
  2. Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials.
    Gorabi AM; Abbasifard M; Imani D; Aslani S; Razi B; Alizadeh S; Bagheri-Hosseinabadi Z; Sathyapalan T; Sahebkar A · Phytotherapy research : PTR · 2022
    Meta-analysis32 studies pooledInflammation forCurcumin
  3. Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials.
    Derosa G; Maffioli P; Simental-Mendía LE; Bo S; Sahebkar A · Pharmacological research · 2018
    Meta-analysis9 studies pooledInflammation forCurcumin
  4. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ · Nutrition & metabolism · 2024
    Randomized trial84 participantsInflammation Liver & Detox forCurcumin
  5. Is Curcumin Intake Really Effective for Chronic Inflammatory Metabolic Disease? A Review of Meta-Analyses of Randomized Controlled Trials.
    Lee YM; Kim Y · Nutrients · 2024
    Systematic review54 studies pooledInflammation forCurcumin
  6. Efficacy and safety of curcumin therapy for knee osteoarthritis: A Bayesian network meta-analysis.
    Zhao J; Liang G; Zhou G; Hong K; Yang W; Liu J; Zeng L · Journal of ethnopharmacology · 2024
    Meta-analysis2,175 participants23 studies pooledJoint Health forCurcumin
  7. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
    Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H · Frontiers in immunology · 2022
    Meta-analysis2,396 participants29 studies pooledJoint Health forCurcumin
  8. The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses.
    Bideshki MV; Jourabchi-Ghadim N; Radkhah N; Behzadi M; Asemani S; Jamilian P; Zarezadeh M · Phytotherapy research : PTR · 2024
    Meta-analysis11 studies pooledJoint Health forCurcumin
  9. The efficacy of high- and low-dose curcumin in knee osteoarthritis: A systematic review and meta-analysis.
    Hsiao AF; Lien YC; Tzeng IS; Liu CT; Chou SH; Horng YS · Complementary therapies in medicine · 2021
    Meta-analysis1,258 participants11 studies pooledJoint Health forCurcumin
  10. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis.
    Zeng L; Yu G; Hao W; Yang K; Chen H · Bioscience reports · 2022
    Meta-analysis1,621 participants15 studies pooledJoint Health forCurcumin
  11. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M · Nutrition reviews · 2024
    Meta-analysis905 participants15 studies pooledLiver & Detox forCurcumin
  12. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Ebrahimzadeh A; Fooladshekan S; Mohseni S; Mohtashamian A; Babajafari S; Sohrabi Z · Food science & nutrition · 2025
    Meta-analysis14 studies pooledLiver & Detox forCurcumin
  13. Curcumin Attenuates Liver Steatosis via Antioxidant and Anti-Inflammatory Pathways in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Yaikwawong M; Kamdee K; Chuengsamarn S · International journal of molecular sciences · 2025
    Randomized trial227 participantsLiver & Detox forCurcumin
  14. A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study.
    T Krishnareddy N; Thomas JV; Nair SS; N Mulakal J; Maliakel BP; Krishnakumar IM · BioMed research international · 2019
    Randomized trial48 participantsLiver & Detox forCurcumin
  15. Further Evidence of Benefits to Mood and Working Memory from Lipidated Curcumin in Healthy Older People: A 12-Week, Double-Blind, Placebo-Controlled, Partial Replication Study.
    Cox KHM; White DJ; Pipingas A; Poorun K; Scholey A · Nutrients · 2021
    Randomized trial80 participantsLongevity forCurcumin
  16. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women.
    Akazawa N; Choi Y; Miyaki A; Tanabe Y; Sugawara J; Ajisaka R; Maeda S · Nutrition research (New York, N.Y.) · 2013
    Clinical trial32 participantsLongevity forCurcumin
  17. A novel phospholipid delivery system of curcumin (Meriva®) preserves muscular mass in healthy aging subjects.
    Franceschi F; Feregalli B; Togni S; Cornelli U; Giacomelli L; Eggenhoffner R; Belcaro G · European review for medical and pharmacological sciences · 2016
    Non-randomized trial86 participantsLongevity forCurcumin
  18. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.
    Nunes YC; Mendes NM; Pereira de Lima E; Chehadi AC; Lamas CB; Haber JFS; Dos Santos Bueno M; Araújo AC; Catharin VCS; Detregiachi CRP; Laurindo LF; Tanaka M; Barbalho SM; Marin MJS · Nutrients · 2024
    Systematic review15 studies pooledLongevity forCurcumin
  19. Curcumin and arterial function in health and disease: impact on oxidative stress and inflammation.
    Fleenor BS; Carlini NA; Campbell MS · Current opinion in clinical nutrition and metabolic care · 2020
    Narrative reviewLongevity forCurcumin